Stocks-UTHR-United Therapeutics Corp

UTHR United Therapeutics Corp

216.02 3.03 (1.42%)
Delayed Prices By NASDAQ, in USD Market Closed
Invest
Stocks-UTHR-United Therapeutics Corp
UTHR United Therapeutics Corp
Invest

FINANCIAL SUMMARY

For the quarter ended 31/12/2022, United Therapeutics Corp's revenues decreased by 4.75% and amounted to 491.50M. Net income decreased by 44.80% to 132.10M. Net assets decreased by NaN to N/A and EPS decreased from 4.91 to 2.67.
UTHR's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
92.17%
Net Profit Margin
25.90%
Operating Margin
50.60%
Return On Investment
10.29%